Virogates
11.30 DKK
+18.95 %
Less than 1K followers
VIRO
First North Denmark
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+18.95 %
+5.61 %
-11.02 %
-15.99 %
-15.36 %
+76.56 %
-36.01 %
-91.38 %
-82.86 %
Virogates is active in medical technology. The company is active in research and development of biomarkers and diagnostic instruments for the healthcare industry. The products are sold under various brands and are used in the identification, analysis and further treatment of diseases, primarily cardiovascular diseases, cancer and neurological diseases. The company was established in 2001 and is headquartered in Birkerød.
Read moreMarket cap
104.91M DKK
Turnover
709.2 DKK
Revenue
5.31M
EBIT %
-197.32 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
7.5
2026
Interim report Q1'26
20.8
2026
Interim report Q2'26
5.11
2026
Interim report Q3'26
All
Research
Press releases
3rd party
ShowingAll content types
ViroGates submits its De Novo application to the U.S. FDA for suPARnostic® TurbiLatex
ViroGates gives notice to convene the Annual General Meeting on 23 April 2026
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools